(prostate specific antigen,
10
2
PSA)
2020
7
8
2
1
2
75
PSA
4
10
3
4
5
PSA
PSA
PSA
1)
2)
(
)
2
3
15
10
75
3
(da Vinchi)
2012
4
7cm
800ml
1200ml
3
10%
3-8
5
10
96.7%
LH-RH agonist
3
1.5
90%
(
2.5
PSA
)
QOL
CRT
(
)
CT
1
2003
7
30
I-125
7
2006
( )3D
40
3D3D-CRT
IMRT
2
10-20
HIFU
100
280
2012
4